Back to Top

Information For Authors


Please follow all instructions carefully.  Noncompliance may result in your manuscript being returned to you to be modified to the Journal style before entering the review process.

Create an Account in Manuscript Central

If you do not already have an account in Manuscript Central (MC) for 3D Printing and Additive Manufacturing, you will need to create one.  The system will prompt you for required  information.  Once you create your account, you may log in to the system to begin your submission.  Manuscripts MUST be submitted online (only Word docs, not PDFs) using the following URL:


Keywords (Areas of Expertise)

To facilitate the peer review process, select 4-6 keywords from the drop-down list of pre-selected terms when submitting your manuscript.   These keywords will assist in the selection of skilled reviewers in the field for the purposes of peer review.



All submitting authors are required to complete their submissions using an ORCID identifier. Please visit the ORCID website for more information, or to register.

Authorship.  All authors, including the co-authors, should be responsible for a significant part of the manuscript.  All authors and co-authors should have taken part in writing the manuscript, reviewing it, and revising its intellectual and technical content.   Any author whose name appears on a paper assumes responsibility and accountability for the results.

Submitting Author/Agent:  It is incumbent upon the submitting author/agent  to ensure the accuracy and inclusion of all contributing authors’ names and affiliations upon original submission of the paper. Once a paper is accepted for publication, changes in authorship – including at the page proof stage – are NOT permitted. 


Article Type

Maximum Word Limit*

Abstract Word Limit











7,500 – 10,000






Short Reports


















Letter to the Editor




1 OR


*These limits relate to the text of the manuscript; word limits do NOT include the abstract, figure and/or table legends, acknowledgments, disclosures, or references.

Title page:

The title page of your submission must be included as part of your main text document (not as a separate file) and must include the following items:

  • The complete title of the article
  • All contributing authors’ full names, complete affiliation(s) and mailing address(es), full contact information (telephone, fax, and valid e-mail address)
  • A brief running title (no more than 50 characters, including spaces)
  • The corresponding author’s complete contact information including address, working fax number, and e-mail address

  • Manuscript keywords (search terms): On the title page of the manuscript, include a minimum of three (3), maximum of six (6), search terms that will aid in the discoverability of the article in indexing services and search engines.  These terms may or may not be different from the terms you selected for the peer review process and areas of expertise.  You will be asked to retype these search terms in the submission form when uploading your manuscript.  These keywords will be included in the published article.  If the search terms entered do not match the manuscript, the manuscript will serve as the default.


For all original and review papers, the next page of the manuscript should consist of an unstructured abstract of no more than 300 words, which should be self-explanatory without reference to the text. References are not permitted in the abstract.

Requirements for Abstract:

  • Abstract should be no more than 300 words
  • Abstract should be unstructured
  • The use of the first person should be avoided

  • Clearly summarize the results and conclusions of the work

  • References are not permitted in the abstract

  • Do not use proprietary or trade names in the title or abstract


Please provide a minimum of four keywords below the abstract.


The text of the manuscript should follow this format: Abstract; Introduction; Materials and Methods; Results; Discussion; Conclusion(s), Acknowledgments; Author Disclosure Statement; and References. All manuscripts should be double-spaced.  For all material sources, such as devices, drugs, etc., indicate manufacturer/supplier name, city, state, and country.  If applicable, include trademark or registered symbols in the abstract at the first mention of a product and/or company name, and again at the first mention in the text. At the end of the manuscript, give the name and full address of the individual to whom correspondence should be directed.


Tables should be prepared in Word.  Do not prepare them in PDFs, Excel, .TIFFs, or .EPS files.  Prepare tables double-spaced, one to a page and in a separate file from the text. Each table must stand alone, i.e., contain all necessary information in the table title and be understood independently of the text. Avoid repetition of information that is given in the text. Supply a title for each table.

Figures and Legends:

Figures must be submitted separately using the following guidelines:

  • Figure legends must be prepared in Word.

  • File names must be in English
  • Do NOT include any illustrations as part of your text file
  • Do NOT prepare any figures in Word, as they are not workable

  • Name figure files using only alphanumeric characters.  Do not use spaces, underscores, symbols, dots, or dashes
  • File names should be formatted with the first author’s name and figure number (Ex: SmithFig1)

  • Line illustrations must be submitted at 900 DPI

  • Halftones and color photos should be submitted at a minimum of 300 DPI

  • Save figures as either TIFF or EPS files

  • Color figures* must be saved as CYMK, not RGB

  • Do not include the legend on the figure

  • Figure legends must be prepared as an enumerated list as a separate file after the reference section.

*The Journal will publish color figures, but the author must subsidize the cost. The Publisher will provide the author with a cost estimate when the figures are received if requested.



The use of footnotes is generally discouraged, but can used only when essential.  Prepare footnotes double-spaced on a separate page.  Ensure that there are corresponding citations for footnotes within text.


Collaborations, sources of research funds, and other acknowledgments should be listed in a separate section at the end of the text ahead of the References section.

Author Disclosure Statement:

Immediately following the Acknowledgments section, include a header entitled, “Author Disclosure Statement.” All authors are expected to disclose any institutional or commercial affiliations that might pose a conflict of interest regarding the publication of a manuscript.  Institutional affiliations, as indicated on the title page, should include all corporate affiliations and any funding sources that support the work. Other types of affiliation, including consultancies, honoraria, stock ownership, equity interests, arrangements regarding patents, or other vested interests should also be disclosed in the Disclosure section.  If there are no conflicts to declare, the authors must state, “No competing financial interests exist.”


  • All references must be cited in the text with superscript numbers, in numerical order, beginning with “1.” References must be typed double-spaced and numbered by order of citation.

  • List the first three names of authors, followed by et al.

  • Translate into English all foreign article and book titles.

  • If a work is in press, give the journal in which it is to be published, followed by “in press” in parentheses.

  • Page ranges should be inclusive (Ex:  721-729, not 721-9)

  • Unpublished Material: If a reference refers to unpublished data, a manuscript in preparation, or a manuscript submitted but not in press, it should be included in  parentheses in the body of the text, and not cited in the reference list.  Personal communications should be cited parenthetically in text only, and should not be included in the reference section.

  • Journal abbreviations should follow Medline style.


Journal Articles:  Meseguer-Olmo L, Vicente-Oretga V, Alcaraz-Baños M, et al.  In-vivo behavior of Si-hydroxyapatite polycaprolactone/DMB scaffolds fabricated by 3D printing.  J Biomed Mater Res A 2013;101:2038-2048.

Books:  Lipson H, Kurman M. Fabricated: The New World of 3D Printing. New York, NY: John Wiley & Sons, 2013.

Chapter in a Book: Lipson H, Kurman M. Designing the future. In: Fabricated: The New World of 3D Printing. New York, NY: John Wiley & Sons, 2013, pp.241-261.

  • Please follow this structure, including capitalization and punctuation, for alternative types of references below:

Websites:  List author/organization name (if available).  Article title.  Provide website site.  Include last accessed date.

Conference Proceedings:  List all Authors’ (or) Editors’ names (last name first, followed by first and middle initials).  Conference title. Date of conference. Location of conference. City of publisher: Publisher; Year of publication. Complete number of pages in proceedings book.


When submitting your REVISED manuscript after peer review, please be sure to follow the instructions for resubmission that will be provided in the email that contains the reviews of your paper.  Log on to Manuscript Central and go to your Author Center, and following the directions for resubmitting revisions.  If the deadline for submitting your revision has passed, please contact the Editorial Office or the Publisher to request an extension.  Please do NOT create a new submission for revised manuscripts. 

Uploading manuscript REVISIONS after peer review: Please ensure that you have uploaded the following items for any revised manuscript:

1. EACH REVISION must be submitted with the corrected document (only Word files, not PDFs) showing visible track changes as well as a clean document (without track changes).

2. EACH REVISION should be COMPLETE with title page, author contact information, abstract, references, etc.  (Follow the same instructions as provided for original submissions.)

3. ALL figures and tables are to be uploaded with EACH REVISION.


Our dynamic Author Benefits Program provides you with end-to-end benefits that ensure your hard work pays off and your published manuscript gets the attention it deserves not just upon publication, but permanently.

Liebert Open Access

Ensure maximum visibility, discoverability, and impact for your article with our Liebert Open Access (OA) option

Explore Liebert Open Access

Does your research funder have an open access mandate or would you like to expand the dissemination of your research?

The Liebert Open Access option enables authors to publish open access in our esteemed subscription-based journals.

The benefits of Liebert Open Access include:

  • High visibility; open access articles are freely available online upon publication
  • You retain copyright with the open access license allowing broad dissemination of your research
  • You can freely share your article in repositories and research networks without restrictions
  • Easy compliance with open access mandates
  • Rigorous editorial and peer-review
  • Targeted email announcement featuring a direct link to article

Identification and Marketing

Open access articles are listed with an OA icon in journal tables of content (TOC), TOC alerts, and in marketing announcements. Open access articles are highlighted and promoted in targeted email announcements to thousands of research leaders in your field.

Copyright and Licensing

If you choose to publish with open access, you will retain copyright of your article and a Creative Commons license will be applied. The liberal Creative Commons Attribution 4.0 (CC-BY) license is the default open access license used at Mary Ann Liebert, Inc., publishers. The CC-BY license permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited.

At this time we allow authors to choose between the CC-BY or CC-BY-NonCommercial license. A limited number of journals offer NonCommercial licenses exclusively.

Ordering Open Access

Once your article has been accepted for publication in a journal, you will receive an email with information on ordering Liebert Open Access. If you would like more information about Liebert Open Access or would like to order open access, please email

Publishing open access includes an article publication charge (APC) and authors are asked to fill out a short open access order form.  You can pay by credit card or receive an invoice to be returned with payment or via bank transfer. Please remember that traditional subscription journals can carry mandatory or optional author fees. The Liebert Open Access APC does not cover or replace existing publication or author fees.

Publishing biomedical or biotechnology research?

Biomedical researchers should consider publishing in BioResearch Open Access, a fully open access peer-reviewed journal dedicated to publishing top research in the biomedical and biotechnology fields. For details, please visit the information for authors on the journal website.

 *Please note that PubMedCentral, not the Publisher, has sole control over when the paper is made live on PMC.


Browse journals in the Liebert Open Access portfolio:

NIH Public Access Policy: In order to assist our authors who have NIH funding to comply with this policy, Mary Ann Liebert, Inc. publishers will deposit the final accepted paper (after copy-editing and proofreading) to PubMed Central (PMC) on behalf of the authors. Authors need not take any action. The manuscript's public access posting on PMC will occur 12 months after final publication. This service is provided free of charge. Please note that authors may not deposit manuscripts directly to PMC or other sites without permission from Mary Ann Liebert, Inc.

Publishing in Subscription Journals

By signing the copyright transfer statement, authors still retain a set of rights that allow for self-archiving.

Authors may archive their preprint manuscripts (version prior to peer review) at any time without restrictions. Authors may archive their postprint manuscripts (accepted version after peer review) in institutional repositories, preprint servers, and research networks after a 12 month embargo. The 12 month embargo period begins when the article is published online. Postprints must not be used for commercial purposes and acknowledgement must be given to the final publication, and publisher, by inserting the DOI number of the article in the following sentence: “Final publication is available from Mary Ann Liebert, Inc., publishers[insert DOI]”. Authors may archive on their personal website without an embargo provided their manuscript is updated with an acknowledgement to the publisher copyright and final published version.

The final published article (version of record) can never be archived in a repository, preprint server, or research network.


Publishing Open Access

Authors that wish to easily comply with funder or institutional open access mandates should consider publishing open access. Liebert Open Access option allows authors to make their research freely available online without restrictions. Additionally, Liebert Open Access option allows authors to retain copyright, archive and share the final published version of their article without restrictions. To publish open access please email or visit Liebert Open Access for more information.

The views, opinions, findings, conclusions and recommendations set forth in any Journal article are solely those of the authors of those articles and do not necessarily reflect the views, policy or position of the Journal, its Publisher, its editorial staff or any affiliated Societies and should not be attributed to any of them.